Crescent Energy Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated December 12, 2025, details the completion of Crescent Energy Company's (Crescent) acquisition of Vital Energy, Inc. (Vital). The transaction closed on December 15, 2025 (the "Closing Date"), pursuant to a previously announced Agreement and Plan of Merger. Following the merger, Crescent executed an internal reorganization to integrate Vital's assets and debt obligations into its operating structure.
Key Financial Metrics and Debt Assumption
The filing does not provide specific revenue, profit, or cash flow figures for the combined entity in this report; however, it details the assumption of significant debt obligations by Crescent Finance, LLC, as the successor to Vital. The following senior unsecured notes were assumed:
- Vital 2029 Notes: 7.75% Senior Notes due July 31, 2029. Interest is payable semi-annually.
- Vital 2030 Notes: 9.750% Senior Notes due October 15, 2030. Interest is payable semi-annually.
- Vital 2032 Notes: $800,000,000 aggregate principal amount of 7.875% Senior Notes due April 15, 2032. These notes are guaranteed by certain subsidiaries.
Pro forma financial information for the combined entity was previously filed on November 5, 2025, and is not restated in this document.
Material Changes and Transaction Mechanics
The primary material change is the consolidation of Vital into Crescent. Key transaction mechanics include:
- Merger Consideration: Each eligible share of Vital common stock was converted into the right to receive 1.9062 shares of Crescent Class A common stock. Cash was paid in lieu of fractional shares.
- Equity Awards: Vital stock options were converted to Crescent options. Time-based restricted stock awards vested immediately and were converted to merger consideration. Performance-based cash-settled awards vested at target levels and were settled in cash.
- Debt Restructuring: Crescent Finance assumed all obligations under Vital's outstanding indentures. Supplemental indentures were executed to effectuate this assumption and, in some cases, to remove certain covenants following an exchange offer and consent solicitation.
Guidance, Outlook, and Governance Changes
The filing does not contain forward-looking guidance, earnings outlook, or management commentary regarding future operational performance. However, it notes significant governance changes effective upon the Closing Date:
- Board Composition: The Crescent Board size increased to twelve members. William Albrecht (former Vital Chairman) and Jarvis Hollingsworth (former Vital Director) were appointed as new directors.
- Resignations: Michael Duginski resigned from the Crescent Board and the Nominating & Governance Committee effective December 14, 2025, to facilitate the new appointments.
- Stockholder Approval: At a Special Meeting on December 12, 2025, stockholders approved the issuance of shares for the merger with 207,032,108 votes in favor versus 3,813,274 against.
Investor Verification Checklist
- Verify the final exchange ratio of 1.9062 Crescent shares for each Vital share and the treatment of fractional shares.
- Review the specific covenants removed from the Vital 2029 and 2030 Notes indentures via the supplemental indentures dated December 12, 2025.
- Confirm the total aggregate principal amount of the assumed debt, specifically noting the $800 million principal for the 2032 Notes.
- Examine the pro forma financial statements filed on November 5, 2025, for a complete picture of the combined entity's leverage and liquidity.
- Check the settlement details for Vital's cash-settled performance stock units and director deferred compensation awards.